Experimental study demonstrates near-infrared detection and inhibition of amyloid beta oligomers, suggesting a dual diagnostic and therapeutic strategy for early Alzheimer's disease.
This work holds great promise in the early detection of AD and may also provide an innovative approach to decelerate and even halt AD onset and progression.
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: